EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

ANO2 Genetic Variants and Anti-VEGF Treatment Response in Neovascular AMD: A Pharmacogenetic Substudy of VIEW 1 and VIEW 2

Robyn H Guymer, Rufino Silva, Mercedeh Ghadessi, Sergio Leal, Isabella Gashaw, Amy Damask, Charles Paulding, Kay D Rittenhouse

Investigative Ophthalmology & Visual Science · 2024

DOI: 10.1167/iovs.65.8.17 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Investigative Ophthalmology & Visual Science, 2024. Verfasst von Robyn H Guymer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia. Hauptthemen laut MEDLINE: Intravitreal Injections, Angiogenesis Inhibitors, Visual Acuity, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intravitreal InjectionsAngiogenesis InhibitorsVisual AcuityVascular Endothelial Growth Factor ARanibizumabRecombinant Fusion ProteinsGenome-Wide Association StudyPolymorphism, Single NucleotideReceptors, Vascular Endothelial Growth FactorAnoctaminsHumansMaleFemaleAgedWet Macular DegenerationAged, 80 and overGenotypeTreatment OutcomePharmacogeneticsPharmacogenomic Testing

Substanzen

Angiogenesis InhibitorsVascular Endothelial Growth Factor ARanibizumabRecombinant Fusion ProteinsReceptors, Vascular Endothelial Growth FactorafliberceptAnoctaminsVEGFA protein, human

Autor:innen und Institutionen

  • Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia.
  • The University of Melbourne, Melbourne, Australia.
  • Faculty of Medicine, University of Coimbra (FMUC-UC), Coimbra, Portugal.
  • Unidade Local de Saude de Coimbra (ULS-Coimbra), Coimbra, Portugal.
  • Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, Portugal.
  • Clinical and Academic Centre of Coimbra (CACC), Coimbra, Portugal.

Zitieren

APA

Guymer, R. H., Silva, R., Ghadessi, M., Leal, S., Gashaw, I., Damask, A., Paulding, C., & Rittenhouse, K. D. (2024). ANO2 Genetic Variants and Anti-VEGF Treatment Response in Neovascular AMD: A Pharmacogenetic Substudy of VIEW 1 and VIEW 2. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.65.8.17

Vancouver

Guymer RH, Silva R, Ghadessi M, Leal S, Gashaw I, Damask A, et al. ANO2 Genetic Variants and Anti-VEGF Treatment Response in Neovascular AMD: A Pharmacogenetic Substudy of VIEW 1 and VIEW 2. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.8.17

BibTeX
@article{Guymer2024,
  author = {Guymer, Robyn H and Silva, Rufino and Ghadessi, Mercedeh and Leal, Sergio and Gashaw, Isabella and Damask, Amy and Paulding, Charles and Rittenhouse, Kay D},
  title = {ANO2 Genetic Variants and Anti-VEGF Treatment Response in Neovascular AMD: A Pharmacogenetic Substudy of VIEW 1 and VIEW 2},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2024},
  doi = {10.1167/iovs.65.8.17}
}
Kostenlos starten →